Literature DB >> 30658725

Effect of ethanol on lipid metabolism.

Min You1, Gavin E Arteel2.   

Abstract

Hepatic lipid metabolism is a series of complex processes that control influx and efflux of not only hepatic lipid pools, but also organismal pools. Lipid homeostasis is usually tightly controlled by expression, substrate supply, oxidation and secretion that keep hepatic lipid pools relatively constant. However, perturbations of any of these processes can lead to lipid accumulation in the liver. Although it is thought that these responses are hepatic arms of the 'thrifty genome', they are maladaptive in the context of chronic fatty liver diseases. Ethanol is likely unique among toxins, in that it perturbs almost all aspects of hepatic lipid metabolism. This complex response is due in part to the large metabolic demand placed on the organ by alcohol metabolism, but also appears to involve more nuanced changes in expression and substrate supply. The net effect is that steatosis is a rapid response to alcohol abuse. Although transient steatosis is largely an inert pathology, the chronicity of alcohol-related liver disease seems to require steatosis. Better and more specific understanding of the mechanisms by which alcohol causes steatosis may therefore translate into targeted therapies to treat alcohol-related liver disease and/or prevent its progression.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Alcohol-related liver disease; Lipid homeostasis; Metabolism; Steatosis

Mesh:

Substances:

Year:  2019        PMID: 30658725      PMCID: PMC6436537          DOI: 10.1016/j.jhep.2018.10.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  181 in total

Review 1.  The emerging roles of fatty acid translocase/CD36 and the aryl hydrocarbon receptor in fatty liver disease.

Authors:  Jinhan He; Jung Hoon Lee; Maria Febbraio; Wen Xie
Journal:  Exp Biol Med (Maywood)       Date:  2011-09-01

Review 2.  Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease.

Authors:  Peter Stärkel; Bernd Schnabl
Journal:  Semin Liver Dis       Date:  2016-12-20       Impact factor: 6.115

3.  Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle.

Authors:  S H Park; S R Gammon; J D Knippers; S R Paulsen; D S Rubink; W W Winder
Journal:  J Appl Physiol (1985)       Date:  2002-06

4.  S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet.

Authors:  Farah Esfandiari; Min You; Jesus A Villanueva; Donna H Wong; Samuel W French; Charles H Halsted
Journal:  Alcohol Clin Exp Res       Date:  2007-07       Impact factor: 3.455

5.  Effects of ethanol on the metabolism of free fatty acids in isolated liver cells.

Authors:  J A Ontko
Journal:  J Lipid Res       Date:  1973-01       Impact factor: 5.922

6.  Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

Authors:  Wenliang Zhang; Qian Sun; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

Review 7.  Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.

Authors:  P Ferré; F Foufelle
Journal:  Diabetes Obes Metab       Date:  2010-10       Impact factor: 6.577

8.  Liver fattening during feast and famine: an evolutionary paradox.

Authors:  Vincent J T van Ginneken
Journal:  Med Hypotheses       Date:  2007-12-03       Impact factor: 1.538

9.  The possible mechanisms of CYP2E1 interactions with HSP90 and the influence of ethanol on them.

Authors:  Volodymyr O Kitam; Oksana V Maksymchuk; Mykola O Chashchyn
Journal:  BMC Struct Biol       Date:  2012-12-17

10.  Autophagy Protects against CYP2E1/Chronic Ethanol-Induced Hepatotoxicity.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Biomolecules       Date:  2015-10-16
View more
  55 in total

Review 1.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 2.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

3.  Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane.

Authors:  Robin H Isaacson; Juliane I Beier; Nicholas Kh Khoo; Bruce A Freeman; Zachary Freyberg; Gavin E Arteel
Journal:  J Nutr Biochem       Date:  2020-04-08       Impact factor: 6.048

Review 4.  Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  Metabolites       Date:  2020-01-28

5.  Alcohol-related liver disease: Time for action.

Authors:  Ramon Bataller; Gavin E Arteel; Christophe Moreno; Vijay Shah
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

6.  Hepatocyte-derived MANF mitigates ethanol-induced liver steatosis in mice via enhancing ASS1 activity and activating AMPK pathway.

Authors:  Han-Yang Xu; Yan-Hong Jiao; Shi-Yu Li; Xu Zhu; Sheng Wang; Yu-Yang Zhang; Yi-Jun Wei; Yu-Jun Shen; Wei Wang; Yu-Xian Shen; Jun-Tang Shao
Journal:  Acta Pharmacol Sin       Date:  2022-06-02       Impact factor: 6.150

7.  Plasma lipidomics analysis reveals altered lipids signature in patients with osteonecrosis of the femoral head.

Authors:  Yuzhu Yan; Jihan Wang; Dageng Huang; Jing Lv; Hui Li; Jing An; Xiaojian Cui; Heping Zhao
Journal:  Metabolomics       Date:  2022-02-11       Impact factor: 4.290

8.  Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?

Authors:  Andre J Jeyarajan; Raymond T Chung
Journal:  J Infect Dis       Date:  2020-11-27       Impact factor: 5.226

9.  Polygenic risk score for alcohol drinking behavior improves prediction of inflammatory bowel disease risk.

Authors:  Antonio F Di Narzo; Amy Hart; Roman Kosoy; Lauren Peters; Aleksandar Stojmirovic; Haoxiang Cheng; Zhongyang Zhang; Mingxu Shan; Judy Cho; Andrew Kasarskis; Carmen Argmann; Inga Peter; Eric E Schadt; Ke Hao
Journal:  Hum Mol Genet       Date:  2021-04-30       Impact factor: 6.150

Review 10.  Pathophysiological Aspects of Alcohol Metabolism in the Liver.

Authors:  Jeongeun Hyun; Jinsol Han; Chanbin Lee; Myunghee Yoon; Youngmi Jung
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.